Facebook
Twitter
Telegram
Report an ErrorKymera Therapeutics Financial Statements 2011-2024 | KYMR
Annual Financial Statements Kymera Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.33 B | 1.78 B | 2.02 B | 1.07 B | - | - | - | - | - | - | - | - | - |
Shares |
58.4 M | 53.9 M | 48 M | 17.3 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
40 | 33 | 42 | 62 | - | - | - | - | - | - | - | - | - |
Net Income |
-147 M | -155 M | -100 M | -45.6 M | -41.2 M | -21.5 M | - | - | - | - | - | - | - |
Revenue |
78.6 M | 46.8 M | 72.8 M | 34 M | 2.93 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-166 M | -161 M | -101 M | -46.3 M | -42.2 M | - | - | - | - | - | - | - | - |
Interest Expense |
18.6 M | 6.45 M | 313 K | 711 K | 959 K | - | - | - | - | - | - | - | - |
EBITDA |
-162 M | -158 M | -98.1 M | -44.5 M | -41.4 M | -21.2 M | - | - | - | - | - | - | - |
Operating Expenses |
244 M | 208 M | 173 M | 80.3 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
55 M | 43.8 M | 36.3 M | 18.2 M | 7.98 M | 3.77 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Kymera Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
70.8 M | 55.6 M | 58.4 M | 58.3 M | 58.2 M | 55 M | 54.5 M | 51.8 M | 51.7 M | 51.5 M | 50.7 M | 45.1 M | 44.6 M | 44.5 M | 20.7 M | 2 M | 1.95 M | 1.93 M | 1.75 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-48.6 M | - | -52.9 M | -38.8 M | -40.9 M | - | -43 M | -40.3 M | -36.7 M | - | -28.6 M | -24.7 M | -13.1 M | - | -7.99 M | -14 M | -10.9 M | - | -11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
10.3 M | - | 4.73 M | 16.5 M | 9.47 M | - | 9.55 M | 11.5 M | 9.62 M | - | 20.3 M | 18.5 M | 18.7 M | - | 14.5 M | 3.29 M | 3.43 M | - | 950 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-57.8 M | - | -57.5 M | -43.4 M | -45.3 M | - | -44.9 M | -40.8 M | -36.9 M | - | -28.6 M | -24.7 M | -13.2 M | - | -8.08 M | -14.2 M | -11.2 M | - | -11.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
9.27 M | - | 4.64 M | 4.58 M | 4.4 M | - | 1.88 M | 553 K | 249 K | - | 55 K | 70 K | 94 K | - | 97 K | 203 K | 315 K | - | 441 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-56.4 M | - | -56.6 M | -42.5 M | -44.4 M | - | -44.1 M | -40.1 M | -36.2 M | - | -26.9 M | -23.7 M | -12.7 M | - | -6.82 M | -13.4 M | -10.9 M | - | -11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
68.1 M | - | 62.2 M | 59.9 M | 54.8 M | - | 54.4 M | 52.3 M | 46.6 M | - | 49 M | 43.2 M | 31.9 M | - | 22.6 M | 17.5 M | 14.7 M | - | 12.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
14.4 M | - | 14.1 M | 14.1 M | 12.6 M | - | 10.6 M | 11 M | 10.6 M | - | 10.7 M | 8.03 M | 5.91 M | - | 6.84 M | 3.66 M | 2.56 M | - | 1.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency